CA Stock MarketDetailed Quotes

EAST.H EastWest Bioscience Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Nov 19 09:30 ET
2.52MMarket Cap0.00P/E (TTM)

EastWest Bioscience Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2022
(Q2)Jan 31, 2022
(Q1)Oct 31, 2021
(FY)Jul 31, 2021
(Q4)Jul 31, 2021
(Q3)Apr 30, 2021
(Q2)Jan 31, 2021
(Q1)Oct 31, 2020
(FY)Jul 31, 2020
(Q4)Jul 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-107.04%-4.28K
82.77%-44.3K
107.86%10.22K
-112.21%-688.47K
-206.01%-362.13K
208.76%60.75K
-404.50%-257.12K
-30.93%-129.97K
85.88%-324.43K
-115.63%-118.34K
Net income from continuing operations
-269.36%-560.94K
1,103.13%2.09M
-83.59%-571.68K
-43.78%-1.63M
-228.55%-956.4K
59.47%-151.87K
-393.97%-208.19K
26.60%-311.4K
68.97%-1.13M
76.12%-291.1K
Operating gains losses
561.82%324.08K
----
----
72.36%-129.26K
86.69%-25.08K
-229.00%-70.18K
99.58%-1.29K
-9.69%-32.71K
-3,387.91%-467.67K
---188.39K
Depreciation and amortization
-18.46%24.97K
-12.05%24.97K
-15.38%24.97K
-6.49%118.49K
-21.95%29.98K
17.66%30.62K
-2.07%28.39K
-11.37%29.51K
-6.53%126.71K
-26.50%38.4K
Asset impairment expenditure
--2.35K
--0
-113.82%-2.35K
317.08%235.47K
472.36%218.47K
--0
--0
--17K
-88.34%56.46K
--38.17K
Remuneration paid in stock
167.04%22.46K
53.71%23.27K
-1.13%41.42K
152.64%186.36K
229.96%120.91K
-26.36%8.41K
17.34%15.14K
227.44%41.89K
-77.98%73.76K
-64.04%36.65K
Other non cashItems
13.98%11.69K
2,897.50%326.76K
47.60%14.45K
-977.85%-186.32K
-575.44%-217.27K
134.74%10.25K
--10.9K
--9.79K
--21.23K
--45.7K
Change In working capital
-26.72%171.12K
340.89%245.87K
334.16%503.42K
-28.34%714.66K
131.06%467.26K
-1.98%233.51K
-141.14%-102.06K
-62.44%115.95K
160.51%997.25K
-84.72%202.23K
-Change in receivables
163.04%30.9K
11.18%-40.9K
-30.07%13.55K
-89.82%26.95K
-34.10%102.65K
-146.07%-49.02K
41.30%-46.05K
-90.66%19.38K
509.29%264.79K
-52.12%155.76K
-Change in inventory
-233.94%-45.27K
206.83%44.7K
-146.29%-10.26K
-98.09%6.1K
-190.32%-8.02K
2,607.20%33.8K
-128.02%-41.84K
-86.31%22.17K
89.42%318.82K
-98.93%8.88K
-Change in prepaid assets
359.30%32.36K
-138.89%-31.92K
146.78%36.9K
-48.39%56.02K
57.30%65.29K
-145.02%-12.48K
867.73%82.08K
-355.78%-78.88K
551.02%108.54K
-52.37%41.5K
-Change in payables and accrued expense
-42.75%148.96K
1,899.54%228.92K
312.89%427.11K
-26.34%434.24K
-68.80%83.32K
4.57%260.19K
-107.61%-12.72K
210.71%103.44K
218.35%589.52K
270.39%267.06K
-Change in other current liabilities
----
----
----
----
----
----
----
----
--10.51K
----
-Change in other working capital
310.74%4.17K
153.96%45.07K
-27.53%36.12K
164.88%191.35K
179.59%224.03K
105.95%1.02K
-5,033.85%-83.53K
2,498.44%49.84K
-349.78%-294.93K
-218.05%-281.49K
Cash from discontinued investing activities
Operating cash flow
-107.04%-4.28K
82.77%-44.3K
107.86%10.22K
-112.21%-688.47K
-206.01%-362.13K
208.76%60.75K
-404.50%-257.12K
-30.93%-129.97K
85.88%-324.43K
-122.92%-118.34K
Investing cash flow
Cash flow from continuing investing activities
0
-5.51M
-74.46K
-68.70%21.02K
-76.67%30.48K
0
126.88%67.16K
-41.58%130.62K
Net PPE purchase and sale
--0
--2
---74.46K
-77.38%21.02K
2,573.86%30.48K
----
----
--0
416.04%92.92K
-101.44%-1.23K
Net business purchase and sale
--0
----
----
----
----
----
----
----
93.13%-25.76K
----
Cash from discontinued investing activities
Investing cash flow
--0
---5.51M
---74.46K
-68.70%21.02K
-76.67%30.48K
94.57%-9.46K
--0
--0
126.88%67.16K
-38.17%130.62K
Financing cash flow
Cash flow from continuing financing activities
-99.99%2
1,703.49%4.61M
-138.57%-20K
422.10%1.62M
3,093.05%1.27M
-86.28%39.95K
1,672.46%255.41K
11.82%51.85K
-76.36%309.55K
95.48%-42.4K
Net issuance payments of debt
-99.99%2
-29.87%20K
-138.57%-20K
50.49%334.95K
750.62%222.68K
-86.31%31.9K
15.30%28.52K
5,178.45%51.85K
-37.23%222.56K
-771.33%-34.23K
Net common stock issuance
----
----
----
1,372.91%1.28M
----
----
----
----
-90.89%86.98K
----
Net other financing activities
--0
----
----
----
----
-86.14%8.05K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.99%2
1,703.49%4.61M
-138.57%-20K
422.10%1.62M
3,093.05%1.27M
-86.28%39.95K
1,672.46%255.41K
11.82%51.85K
-76.36%309.55K
95.48%-42.4K
Net cash flow
Beginning cash position
-11.04%24.25K
3,254.30%971.54K
885.94%1.06M
95.38%107.08K
-13.62%118.5K
-64.15%27.26K
-18.81%28.96K
95.38%107.08K
-95.76%54.81K
-48.45%137.2K
Current changes in cash
-104.69%-4.28K
-55,427.02%-947.29K
-7.84%-84.24K
1,714.79%948.7K
3,212.54%937.28K
49.20%91.25K
-104.23%-1.71K
-308.28%-78.12K
104.22%52.28K
85.75%-30.11K
End cash Position
-83.15%19.97K
-11.04%24.25K
3,254.30%971.54K
885.94%1.06M
885.94%1.06M
-13.62%118.5K
-64.15%27.26K
-18.81%28.96K
95.38%107.08K
95.38%107.08K
Free cash from
-108.34%-4.28K
82.77%-44.3K
50.57%-64.24K
-114.29%-697.93K
-202.81%-362.13K
191.83%51.3K
-404.50%-257.12K
-30.93%-129.97K
86.00%-325.69K
-110.99%-119.59K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Apr 30, 2022(Q2)Jan 31, 2022(Q1)Oct 31, 2021(FY)Jul 31, 2021(Q4)Jul 31, 2021(Q3)Apr 30, 2021(Q2)Jan 31, 2021(Q1)Oct 31, 2020(FY)Jul 31, 2020(Q4)Jul 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -107.04%-4.28K82.77%-44.3K107.86%10.22K-112.21%-688.47K-206.01%-362.13K208.76%60.75K-404.50%-257.12K-30.93%-129.97K85.88%-324.43K-115.63%-118.34K
Net income from continuing operations -269.36%-560.94K1,103.13%2.09M-83.59%-571.68K-43.78%-1.63M-228.55%-956.4K59.47%-151.87K-393.97%-208.19K26.60%-311.4K68.97%-1.13M76.12%-291.1K
Operating gains losses 561.82%324.08K--------72.36%-129.26K86.69%-25.08K-229.00%-70.18K99.58%-1.29K-9.69%-32.71K-3,387.91%-467.67K---188.39K
Depreciation and amortization -18.46%24.97K-12.05%24.97K-15.38%24.97K-6.49%118.49K-21.95%29.98K17.66%30.62K-2.07%28.39K-11.37%29.51K-6.53%126.71K-26.50%38.4K
Asset impairment expenditure --2.35K--0-113.82%-2.35K317.08%235.47K472.36%218.47K--0--0--17K-88.34%56.46K--38.17K
Remuneration paid in stock 167.04%22.46K53.71%23.27K-1.13%41.42K152.64%186.36K229.96%120.91K-26.36%8.41K17.34%15.14K227.44%41.89K-77.98%73.76K-64.04%36.65K
Other non cashItems 13.98%11.69K2,897.50%326.76K47.60%14.45K-977.85%-186.32K-575.44%-217.27K134.74%10.25K--10.9K--9.79K--21.23K--45.7K
Change In working capital -26.72%171.12K340.89%245.87K334.16%503.42K-28.34%714.66K131.06%467.26K-1.98%233.51K-141.14%-102.06K-62.44%115.95K160.51%997.25K-84.72%202.23K
-Change in receivables 163.04%30.9K11.18%-40.9K-30.07%13.55K-89.82%26.95K-34.10%102.65K-146.07%-49.02K41.30%-46.05K-90.66%19.38K509.29%264.79K-52.12%155.76K
-Change in inventory -233.94%-45.27K206.83%44.7K-146.29%-10.26K-98.09%6.1K-190.32%-8.02K2,607.20%33.8K-128.02%-41.84K-86.31%22.17K89.42%318.82K-98.93%8.88K
-Change in prepaid assets 359.30%32.36K-138.89%-31.92K146.78%36.9K-48.39%56.02K57.30%65.29K-145.02%-12.48K867.73%82.08K-355.78%-78.88K551.02%108.54K-52.37%41.5K
-Change in payables and accrued expense -42.75%148.96K1,899.54%228.92K312.89%427.11K-26.34%434.24K-68.80%83.32K4.57%260.19K-107.61%-12.72K210.71%103.44K218.35%589.52K270.39%267.06K
-Change in other current liabilities ----------------------------------10.51K----
-Change in other working capital 310.74%4.17K153.96%45.07K-27.53%36.12K164.88%191.35K179.59%224.03K105.95%1.02K-5,033.85%-83.53K2,498.44%49.84K-349.78%-294.93K-218.05%-281.49K
Cash from discontinued investing activities
Operating cash flow -107.04%-4.28K82.77%-44.3K107.86%10.22K-112.21%-688.47K-206.01%-362.13K208.76%60.75K-404.50%-257.12K-30.93%-129.97K85.88%-324.43K-122.92%-118.34K
Investing cash flow
Cash flow from continuing investing activities 0-5.51M-74.46K-68.70%21.02K-76.67%30.48K0126.88%67.16K-41.58%130.62K
Net PPE purchase and sale --0--2---74.46K-77.38%21.02K2,573.86%30.48K----------0416.04%92.92K-101.44%-1.23K
Net business purchase and sale --0----------------------------93.13%-25.76K----
Cash from discontinued investing activities
Investing cash flow --0---5.51M---74.46K-68.70%21.02K-76.67%30.48K94.57%-9.46K--0--0126.88%67.16K-38.17%130.62K
Financing cash flow
Cash flow from continuing financing activities -99.99%21,703.49%4.61M-138.57%-20K422.10%1.62M3,093.05%1.27M-86.28%39.95K1,672.46%255.41K11.82%51.85K-76.36%309.55K95.48%-42.4K
Net issuance payments of debt -99.99%2-29.87%20K-138.57%-20K50.49%334.95K750.62%222.68K-86.31%31.9K15.30%28.52K5,178.45%51.85K-37.23%222.56K-771.33%-34.23K
Net common stock issuance ------------1,372.91%1.28M-----------------90.89%86.98K----
Net other financing activities --0-----------------86.14%8.05K----------------
Cash from discontinued financing activities
Financing cash flow -99.99%21,703.49%4.61M-138.57%-20K422.10%1.62M3,093.05%1.27M-86.28%39.95K1,672.46%255.41K11.82%51.85K-76.36%309.55K95.48%-42.4K
Net cash flow
Beginning cash position -11.04%24.25K3,254.30%971.54K885.94%1.06M95.38%107.08K-13.62%118.5K-64.15%27.26K-18.81%28.96K95.38%107.08K-95.76%54.81K-48.45%137.2K
Current changes in cash -104.69%-4.28K-55,427.02%-947.29K-7.84%-84.24K1,714.79%948.7K3,212.54%937.28K49.20%91.25K-104.23%-1.71K-308.28%-78.12K104.22%52.28K85.75%-30.11K
End cash Position -83.15%19.97K-11.04%24.25K3,254.30%971.54K885.94%1.06M885.94%1.06M-13.62%118.5K-64.15%27.26K-18.81%28.96K95.38%107.08K95.38%107.08K
Free cash from -108.34%-4.28K82.77%-44.3K50.57%-64.24K-114.29%-697.93K-202.81%-362.13K191.83%51.3K-404.50%-257.12K-30.93%-129.97K86.00%-325.69K-110.99%-119.59K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data